These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27537361)

  • 21. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
    Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
    Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic and lifestyle predictors of ischemic heart disease and all-cause mortality among normal weight, overweight, and obese men: a 16-year follow-up in the Copenhagen Male Study.
    Suadicani P; Hein HO; von Eyben FE; Gyntelberg F
    Metab Syndr Relat Disord; 2009 Apr; 7(2):97-104. PubMed ID: 19032035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholesterol and glucose levels belong to independent predictors of death and hospitalizations in patients with chronic systolic heart failure].
    Smetanina IN; Deev AD; Gratsianskiĭ NA
    Kardiologiia; 2007; 47(8):12-6. PubMed ID: 18260904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.
    Bosco C; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
    BMC Cancer; 2018 Feb; 18(1):205. PubMed ID: 29463235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Kinjo K; Inoue T; Iseki C; Takishita S
    Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.
    Brancati FL; Whelton PK; Randall BL; Neaton JD; Stamler J; Klag MJ
    JAMA; 1997 Dec; 278(23):2069-74. PubMed ID: 9403420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany.
    Hoffmann F; Haastert B; Koch M; Giani G; Glaeske G; Icks A
    Nephrol Dial Transplant; 2011 May; 26(5):1634-40. PubMed ID: 20959344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
    Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
    PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
    OʼShaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Transplantation; 2017 Oct; 101(10):2636-2647. PubMed ID: 28207635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan Study.
    Han QL; Wu SL; Liu XX; An SS; Wu YT; Gao JS; Chen SH; Liu XK; Zhang Q; Mao RY; Shang XM; Jonas JB
    BMJ Open; 2016 Nov; 6(11):e012486. PubMed ID: 27899399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of macrovascular disease in patients with type 2 diabetes mellitus.
    Abu-Lebdeh HS; Hodge DO; Nguyen TT
    Mayo Clin Proc; 2001 Jul; 76(7):707-12. PubMed ID: 11444403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ
    Kidney Int; 2005 Feb; 67(2):714-20. PubMed ID: 15673321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
    Holme I; Tonstad S
    Eur J Prev Cardiol; 2013 Feb; 20(1):168-75. PubMed ID: 22131130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus.
    Kimmel PL; Varela MP; Peterson RA; Weihs KL; Simmens SJ; Alleyne S; Amarashinge A; Mishkin GJ; Cruz I; Veis JH
    Kidney Int; 2000 Mar; 57(3):1141-51. PubMed ID: 10720966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.